Last reviewed · How we verify
Placebo(for Dexmedetomidine)
A placebo contains no active pharmaceutical ingredient and produces no pharmacological effect.
A placebo contains no active pharmaceutical ingredient and produces no pharmacological effect. Used for Control arm in clinical trials of dexmedetomidine.
At a glance
| Generic name | Placebo(for Dexmedetomidine) |
|---|---|
| Also known as | normal saline |
| Sponsor | Tang-Du Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebo is an inert substance used as a control in clinical trials to compare against the active drug (in this case, dexmedetomidine). Any observed effects are attributable to the placebo effect—psychological and contextual factors rather than direct drug action. Placebos are essential for establishing the true efficacy of investigational or marketed drugs.
Approved indications
- Control arm in clinical trials of dexmedetomidine
Common side effects
Key clinical trials
- Dexmedotomidine for Acute Pain Control in Patients With Multiple Rib FracturesRandomized Controlled Trial (PHASE4)
- Dexmedetomidine for Invasive Ventilation In the NEOnate (PHASE2, PHASE3)
- Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery (NA)
- Safety and Efficacy of Dexmedetomidate vs. Midazolam for Procedural Sedation During Medical Thoracoscopy (PHASE3)
- Use of Dexmedetomidine to Improve Pain Control and Recovery After Laparocopic-Assisted Bowel Surgery in Adults (PHASE3)
- Perioperative Multimodal Analgesia for Supratentorial Craniotomy (NA)
- Perioperative Multimodal Analgesia Protocol for Supratentorial Craniotomy (NA)
- DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo(for Dexmedetomidine) CI brief — competitive landscape report
- Placebo(for Dexmedetomidine) updates RSS · CI watch RSS
- Tang-Du Hospital portfolio CI